🔗 Share this article

An underground economy for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Several experts said the demand for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer laws, risking penalties, prosecution or prison.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

After minutes of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, medical conditions or past usage.

Item Details and Costs

Within these groups, posts display black plastic parcels with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.